Asensus Surgical, Inc.
ASXC
ASXC was delisted on the 21st of August, 2024.
141 hedge funds and large institutions have $92.3M invested in Asensus Surgical, Inc. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 24 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 31
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 149 → 141 (-8)
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
45% less call options, than puts
Call options by funds: $1.32M | Put options by funds: $2.41M
47% less capital invested
Capital invested by funds: $174M → $92.3M (-$81.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$3.89M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$2.64M |
| 3 |
Morgan Stanley
New York
|
+$1.69M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.67M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$619K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$10.8M |
| 2 |
State Street
Boston,
Massachusetts
|
-$5.59M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$867K |
| 4 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
-$864K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$680K |
ASXC Hedge Fund Activity: Q2 2019 in Review
141 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q2 2019, worth a combined $92.3M — down 47% from $174M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of ASXC and 19 opened new positions — a net loss of 5 holders — while 31 trimmed existing stakes and 45 added.
The largest buyer was Masters Capital Management, adding an estimated $3.89M. The largest seller was JP Morgan Chase, cutting an estimated $10.8M.
- 141 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q2 2019, down from 149 in Q1 2019.
- Funds reported $92.3M of Asensus Surgical, Inc. stock for Q2 2019, down 47% quarter-over-quarter.
- 19 funds opened new Asensus Surgical, Inc. positions in Q2 2019 and 24 closed out, a net change of -5 holders.
- The largest Asensus Surgical, Inc. buyer in Q2 2019 was Masters Capital Management, an estimated $3.89M added.
- The largest Asensus Surgical, Inc. seller in Q2 2019 was JP Morgan Chase, an estimated $10.8M sold.
Based on aggregated 13F filings for Q2 2019.